A vocal minority who are opposed to using tissue plasminogen activator (TPA) for treating strokes is contributing to fewer patients receiving the clot-busting drug, the New York Times reported.

Edwards Lifesciences notched a victory in its ongoing dispute with Boston Scientific concerning transcatheter aortic valve replacement (TAVR) patents.

BOCA RATON, Fla., March 27, 2018 — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years.

Though a significant amount of literature currently exists regarding high cholesterol as a risk factor for cardiovascular disease (CVD), less than 40 percent of people with high cholesterol levels are prescribed the correct drug treatments, according to new research published in the American Heart Association’s journal Circulation.

Two editors of JACC: Heart Failure detailed how the United States has fallen behind other countries in site-based clinical research and offered suggestions on how to reinvigorate the research culture in America.

A resting systolic blood pressure above 120 to 125 millimeters of mercury was associated with a more rapid increase toward full-on hypertension, according to an analysis of the Framingham Heart Study published in JAMA Cardiology.

In a perspective piece published by The New York Times, Indiana University pediatrics professor and healthcare blogger Aaron E. Carroll, MD, offered his take on a recent JAMA study showing near-equal weight loss with a low-fat versus a low-carbohydrate diet.

Losing two or more teeth during middle age is associated with increased cardiovascular disease (CVD) risk, according to recently presented findings at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Session 2018 on March 21 in New Orleans.